Atopic Dermatitis Is an IL-13–Dominant Disease with Greater Molecular Heterogeneity Compared to Psoriasis-Reference-Cited by-同舟云学术

Atopic Dermatitis Is an IL-13–Dominant Disease with Greater Molecular Heterogeneity Compared to Psoriasis

Published:2019-07 Issue:7 Volume:139 Page:1480-1489
ISSN:0022-202X
Container-title:Journal of Investigative Dermatology
language:en
Short-container-title:Journal of Investigative Dermatology

Author:

Tsoi Lam C.,Rodriguez Elke,Degenhardt Frauke,Baurecht Hansjörg,Wehkamp Ulrike,Volks Natalie,Szymczak Silke,Swindell William R.,Sarkar Mrinal K.,Raja Kalpana,Shao Shuai,Patrick Matthew,Gao Yilin,Uppala Ranjitha,Perez White Bethany E,Getsios Spiro,Harms Paul W.,Maverakis Emanual,Elder James T.,Franke Andre,Gudjonsson Johann E.,Weidinger Stephan

Publisher

Elsevier BV

Subject

Cell Biology,Dermatology,Molecular Biology,Biochemistry

Reference53 articles.

1. HTSeq—a Python framework to work with high-throughput sequencing data;Anders;Bioinformatics,2015

2. Genome-wide comparative analysis of atopic dermatitis and psoriasis gives insight into opposing genetic mechanisms;Baurecht;Am J Human Genet,2015

3. Topical tofacitinib for atopic dermatitis: a phase IIa randomized trial;Bissonnette;Br J Dermatol,2016

4. Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial;Blauvelt;Lancet,2017

Cited by 313 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lebrikizumab▼: Short and Long-Term Disease Control in Moderate-to-Severe AD Through Selective IL-13 Inhibition;European Medical Journal;2024-09-12

2. Co-Expression Network and Machine Learning Analysis of Transcriptomics Data Identifies Distinct Gene Signatures and Pathways in Lesional and Non-Lesional Atopic Dermatitis;Journal of Personalized Medicine;2024-09-10

3. Lebrikizumab Combined with Topical Corticosteroids Improves Patient-reported Outcomes in Japanese Patients with Moderate-to-severe Atopic Dermatitis;Acta Dermato-Venereologica;2024-09-09

4. The binding of extracellular cyclophilin A to ACE2 and CD147 triggers psoriasis-like inflammation;Journal of Autoimmunity;2024-09

5. Epidermal proteomics demonstrates Elafin as a psoriasis‐specific biomarker and highlights increased anti‐inflammatory activity around psoriatic plaques;Journal of the European Academy of Dermatology and Venereology;2024-08-19